BoylanPMAbdallaMBissellBMaleskerMASantibañezMSmithZ.Theophylline for the management of respiratory disorders in adults in the 21st century: a scoping review from the American College of Clinical Pharmacy Pulmonary Practice and Research Network. Pharmacotherapy. 2023;43(9):963-990. doi:10.1002/phar.2843.
2.
BarnesPJ.Theophylline. Am J Respir Crit Care Med. 2013;188(8):901-906. doi:10.1164/rccm.201302-0388PP.
3.
EvansWESchentagJJJuskoWJ, eds. Theophylline. In: Applied pharmacokinetics: principles of therapeutic drug monitoring. 3rd ed.Vancouver, WA: Applied Therapeutics; 1992;17.
4.
WhiteCMSicignanoDJSmithK.Impact of interferons and biological drug inhibitors of IL-2 and IL-6 on small-molecule drug metabolism through the cytochrome P450 system. Ann Pharmacother. 2022;56(2):170-180. doi:10.1177/10600280211022281.
5.
MorganET.Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics. Clin Pharmacol Ther. 2009;85(4):434-438. doi:10.1038/clpt.2008.302.
6.
DebSArrighiS.Potential effects of COVID-19 on cytochrome P450-mediated drug metabolism and disposition in infected patients. Eur J Drug Metab Pharmacokinet. 2021;46(2):185-203. doi:10.1007/s13318-020-00668-8.
7.
LimSYMAl BishtawiBLimW.Role of cytochrome P450 2C9 in COVID-19 treatment: current status and future directions. Eur J Drug Metab Pharmacokinet. 2023;48(3):221-240. doi:10.1007/s13318-023-00826-8.
8.
HornJRHanstenPDChanLN.Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother. 2007;41(4):674-680. doi:10.1345/aph.1H423.